Literature DB >> 35573973

An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain.

Allison J Greaney1, Tyler N Starr2, Jesse D Bloom2.   

Abstract

A key goal of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surveillance is to rapidly identify viral variants with mutations that reduce neutralization by polyclonal antibodies elicited by vaccination or infection. Unfortunately, direct experimental characterization of new viral variants lags their sequence-based identification. Here we help address this challenge by aggregating deep mutational scanning data into an 'escape estimator' that estimates the antigenic effects of arbitrary combinations of mutations to the virus's spike receptor-binding domain. The estimator can be used to intuitively visualize how mutations impact polyclonal antibody recognition and score the expected antigenic effect of combinations of mutations. These scores correlate with neutralization assays performed on SARS-CoV-2 variants and emphasize the ominous antigenic properties of the recently described Omicron variant. An interactive version of the estimator is at https://jbloomlab.github.io/SARS2_RBD_Ab_escape_maps/escape-calc/ (last accessed 11 March 2022), and we provide a Python module for batch processing. Currently the calculator uses primarily data for antibodies elicited by Wuhan-Hu-1-like vaccination or infection and so is expected to work best for calculating escape from such immunity for mutations relative to early SARS-CoV-2 strains.
© The Author(s) 2022. Published by Oxford University Press.

Entities:  

Keywords:  Omicron; SARS-CoV-2 variants; antibody escape; deep mutational scanning; epitope

Year:  2022        PMID: 35573973      PMCID: PMC9092643          DOI: 10.1093/ve/veac021

Source DB:  PubMed          Journal:  Virus Evol        ISSN: 2057-1577


  16 in total

1.  A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.

Authors:  Rui Shi; Chao Shan; Xiaomin Duan; Zhihai Chen; Peipei Liu; Jinwen Song; Tao Song; Xiaoshan Bi; Chao Han; Lianao Wu; Ge Gao; Xue Hu; Yanan Zhang; Zhou Tong; Weijin Huang; William Jun Liu; Guizhen Wu; Bo Zhang; Lan Wang; Jianxun Qi; Hui Feng; Fu-Sheng Wang; Qihui Wang; George Fu Gao; Zhiming Yuan; Jinghua Yan
Journal:  Nature       Date:  2020-05-26       Impact factor: 49.962

2.  SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.

Authors:  Tyler N Starr; Nadine Czudnochowski; Zhuoming Liu; Fabrizia Zatta; Young-Jun Park; Amin Addetia; Dora Pinto; Martina Beltramello; Patrick Hernandez; Allison J Greaney; Roberta Marzi; William G Glass; Ivy Zhang; Adam S Dingens; John E Bowen; M Alejandra Tortorici; Alexandra C Walls; Jason A Wojcechowskyj; Anna De Marco; Laura E Rosen; Jiayi Zhou; Martin Montiel-Ruiz; Hannah Kaiser; Josh R Dillen; Heather Tucker; Jessica Bassi; Chiara Silacci-Fregni; Michael P Housley; Julia di Iulio; Gloria Lombardo; Maria Agostini; Nicole Sprugasci; Katja Culap; Stefano Jaconi; Marcel Meury; Exequiel Dellota; Rana Abdelnabi; Shi-Yan Caroline Foo; Elisabetta Cameroni; Spencer Stumpf; Tristan I Croll; Jay C Nix; Colin Havenar-Daughton; Luca Piccoli; Fabio Benigni; Johan Neyts; Amalio Telenti; Florian A Lempp; Matteo S Pizzuto; John D Chodera; Christy M Hebner; Herbert W Virgin; Sean P J Whelan; David Veesler; Davide Corti; Jesse D Bloom; Gyorgy Snell
Journal:  Nature       Date:  2021-07-14       Impact factor: 69.504

3.  Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.

Authors:  Pengfei Wang; Manoj S Nair; Lihong Liu; Sho Iketani; Yang Luo; Yicheng Guo; Maple Wang; Jian Yu; Baoshan Zhang; Peter D Kwong; Barney S Graham; John R Mascola; Jennifer Y Chang; Michael T Yin; Magdalena Sobieszczyk; Christos A Kyratsous; Lawrence Shapiro; Zizhang Sheng; Yaoxing Huang; David D Ho
Journal:  Nature       Date:  2021-03-08       Impact factor: 69.504

4.  Structural basis of a shared antibody response to SARS-CoV-2.

Authors:  Meng Yuan; Hejun Liu; Nicholas C Wu; Chang-Chun D Lee; Xueyong Zhu; Fangzhu Zhao; Deli Huang; Wenli Yu; Yuanzi Hua; Henry Tien; Thomas F Rogers; Elise Landais; Devin Sok; Joseph G Jardine; Dennis R Burton; Ian A Wilson
Journal:  Science       Date:  2020-07-13       Impact factor: 47.728

5.  Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.

Authors:  Tyler N Starr; Allison J Greaney; Amin Addetia; William W Hannon; Manish C Choudhary; Adam S Dingens; Jonathan Z Li; Jesse D Bloom
Journal:  Science       Date:  2021-01-25       Impact factor: 47.728

6.  Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.

Authors:  Tyler N Starr; Allison J Greaney; Adam S Dingens; Jesse D Bloom
Journal:  Cell Rep Med       Date:  2021-04-05

7.  Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies.

Authors:  Allison J Greaney; Andrea N Loes; Katharine H D Crawford; Tyler N Starr; Keara D Malone; Helen Y Chu; Jesse D Bloom
Journal:  Cell Host Microbe       Date:  2021-02-08       Impact factor: 21.023

8.  Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum.

Authors:  Keiya Uriu; Izumi Kimura; Kotaro Shirakawa; Akifumi Takaori-Kondo; Taka-Aki Nakada; Atsushi Kaneda; So Nakagawa; Kei Sato
Journal:  N Engl J Med       Date:  2021-11-03       Impact factor: 91.245

9.  Convergent antibody responses to SARS-CoV-2 in convalescent individuals.

Authors:  Davide F Robbiani; Christian Gaebler; Frauke Muecksch; Julio C C Lorenzi; Zijun Wang; Alice Cho; Marianna Agudelo; Christopher O Barnes; Anna Gazumyan; Shlomo Finkin; Thomas Hägglöf; Thiago Y Oliveira; Charlotte Viant; Arlene Hurley; Hans-Heinrich Hoffmann; Katrina G Millard; Rhonda G Kost; Melissa Cipolla; Kristie Gordon; Filippo Bianchini; Spencer T Chen; Victor Ramos; Roshni Patel; Juan Dizon; Irina Shimeliovich; Pilar Mendoza; Harald Hartweger; Lilian Nogueira; Maggi Pack; Jill Horowitz; Fabian Schmidt; Yiska Weisblum; Eleftherios Michailidis; Alison W Ashbrook; Eric Waltari; John E Pak; Kathryn E Huey-Tubman; Nicholas Koranda; Pauline R Hoffman; Anthony P West; Charles M Rice; Theodora Hatziioannou; Pamela J Bjorkman; Paul D Bieniasz; Marina Caskey; Michel C Nussenzweig
Journal:  Nature       Date:  2020-06-18       Impact factor: 69.504

10.  Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.

Authors:  Johanna Hansen; Alina Baum; Kristen E Pascal; Vincenzo Russo; Stephanie Giordano; Elzbieta Wloga; Benjamin O Fulton; Ying Yan; Katrina Koon; Krunal Patel; Kyung Min Chung; Aynur Hermann; Erica Ullman; Jonathan Cruz; Ashique Rafique; Tammy Huang; Jeanette Fairhurst; Christen Libertiny; Marine Malbec; Wen-Yi Lee; Richard Welsh; Glen Farr; Seth Pennington; Dipali Deshpande; Jemmie Cheng; Anke Watty; Pascal Bouffard; Robert Babb; Natasha Levenkova; Calvin Chen; Bojie Zhang; Annabel Romero Hernandez; Kei Saotome; Yi Zhou; Matthew Franklin; Sumathi Sivapalasingam; David Chien Lye; Stuart Weston; James Logue; Robert Haupt; Matthew Frieman; Gang Chen; William Olson; Andrew J Murphy; Neil Stahl; George D Yancopoulos; Christos A Kyratsous
Journal:  Science       Date:  2020-06-15       Impact factor: 47.728

View more
  12 in total

1.  Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses.

Authors:  Prashant Bajpai; Vanshika Singh; Anmol Chandele; Sanjeev Kumar
Journal:  Front Cell Infect Microbiol       Date:  2022-06-16       Impact factor: 6.073

2.  A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike.

Authors:  Bernadeta Dadonaite; Katharine H D Crawford; Caelan E Radford; Ariana G Farrell; Timothy C Yu; William W Hannon; Panpan Zhou; Raiees Andrabi; Dennis R Burton; Lihong Liu; David D Ho; Richard A Neher; Jesse D Bloom
Journal:  bioRxiv       Date:  2022-10-13

3.  Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness.

Authors:  Pardis C Sabeti; Jacob E Lemieux; Fritz Obermeyer; Martin Jankowiak; Nikolaos Barkas; Stephen F Schaffner; Jesse D Pyle; Leonid Yurkovetskiy; Matteo Bosso; Daniel J Park; Mehrtash Babadi; Bronwyn L MacInnis; Jeremy Luban
Journal:  Science       Date:  2022-05-24       Impact factor: 63.714

Review 4.  Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.

Authors:  Rekha Khandia; Shailja Singhal; Taha Alqahtani; Mohammad Amjad Kamal; Nahed A El-Shall; Firzan Nainu; Perumal Arumugam Desingu; Kuldeep Dhama
Journal:  Environ Res       Date:  2022-01-29       Impact factor: 8.431

5.  Within-host diversity of SARS-CoV-2 lineages and effect of vaccination.

Authors:  Leo Poon; Haogao Gu; Ahmed Abdul Quadeer; Pavithra Krishnan; Lydia Chang; Gigi Liu; Daisy Ng; Samuel Cheng; Tommy Tsan-Yuk Lam; Malik Peiris; Matthew McKay
Journal:  Res Sq       Date:  2022-08-11

6.  Multi-task learning for predicting SARS-CoV-2 antibody escape.

Authors:  Barak Gross; Roded Sharan
Journal:  Front Genet       Date:  2022-08-11       Impact factor: 4.772

7.  Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa.

Authors:  Kaiyuan Sun; Stefano Tempia; Jackie Kleynhans; Anne von Gottberg; Meredith L McMorrow; Nicole Wolter; Jinal N Bhiman; Jocelyn Moyes; Maimuna Carrim; Neil A Martinson; Kathleen Kahn; Limakatso Lebina; Jacques D du Toit; Thulisa Mkhencele; Cécile Viboud; Cheryl Cohen
Journal:  medRxiv       Date:  2022-08-22

8.  Intrahost SARS-CoV-2 k-mer identification method (iSKIM) for rapid detection of mutations of concern reveals emergence of global mutation patterns.

Authors:  Ashley Thommana; Migun Shakya; Jaykumar Gandhi; Christian K Fung; Patrick S G Chain; Irina Maljkovic Berry; Matthew A Conte
Journal:  bioRxiv       Date:  2022-08-16

9.  On the SARS-CoV-2 BA.2.75 variant: A genetic and structural point of view.

Authors:  Fabio Scarpa; Daria Sanna; Ilenia Azzena; Marta Giovanetti; Domenico Benvenuto; Silvia Angeletti; Giancarlo Ceccarelli; Stefano Pascarella; Marco Casu; Pier Luigi Fiori; Massimo Ciccozzi
Journal:  J Med Virol       Date:  2022-09-04       Impact factor: 20.693

10.  Reduced B cell antigenicity of Omicron lowers host serologic response.

Authors:  Jérôme Tubiana; Yufei Xiang; Li Fan; Haim J Wolfson; Kong Chen; Dina Schneidman-Duhovny; Yi Shi
Journal:  Cell Rep       Date:  2022-09-28       Impact factor: 9.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.